Dublin, April 07, 2025 (GLOBE NEWSWIRE) -- The "Bioavailability and Bioequivalence Studies submitted in NDAs and INDs" training has been added to ResearchAndMarkets.com's offering. Attendees that need ...
Dose-proportional oral bioavailability without clinical signs, including those associated with hallucinogenic compounds, was demonstrated in rat and dog pharmacokinetic (PK) studies while significant ...
PE: Can you elaborate on the key design elements of the AD04 study and how they contributed to achieving positive topline results? Claiborne: The purpose of the study was to evaluate the relative ...
Sequences of topotecan and cisplatin: phase I, pharmacologic, and in vitro studies to examine sequence dependence. Twelve patients with refractory solid tumors were enrolled onto this three-period ...
A draft guidance document provides recommendations for submitting bioavailability information in investigational new drug and new drug applications. FDA published draft guidance on Feb. 25, 2019 on ...